Newbury Pharmaceuticals Investor Relations Material
Latest events
Q3 2025
9 Jul, 2025
Q2 2025
9 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Newbury Pharmaceuticals
Access all reports
Newbury Pharmaceuticals AB is a Sweden-based company specializing in specialty prescription drugs. The company's portfolio includes products across therapeutic areas such as oncology, rare diseases, and neurology. Newbury Pharmaceuticals primarily serves the Scandinavian market, focusing on developing both proprietary and licensed pharmaceutical products. The company is headquartered in Lund, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
NEWBRY
Country
🇸🇪 Sweden